← All trials
NCT03699839
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 26, 2018
- Primary completion
- Jan 31, 2020
- Completion date
- Jun 30, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 780
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of LausanneLead sponsor
- University of LausanneSponsor investigator
- University of ZurichCollaborator
- Cantonal Hospital of St. GallenCollaborator
- University of BaselCollaborator
- University of GenevaCollaborator
- University of BernCollaborator
- Fondazione Epatocentro TicinoCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.